This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kumar, R Articles by Sen, G C Search for Related Content PubMed PubMed Citation Articles by Kumar, R Articles by Sen, G C

 Previous Article  |  Next Article 

J Virol. 1988 September; 62(9): 3175-3181

Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.

Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

ABSTRACT

Interferons inhibit the replication of vesicular stomatitis virus (VSV), but not of encephalomyocarditis virus (EMCV), in mouse JLSV-11 cells. We report the isolation of clonal derivatives from this cell line in which the replication of both viruses is impaired by interferons. These clones were selected from the parental line by virtue of their rescue by interferon treatment from the cytopathic effects of EMCV infection. In one such clone, RK8, the replication of VSV and EMCV and the production of resident murine leukemia virus were inhibited by interferon. On the other hand, in clone RK6, which was isolated without any selection, the replication of VSV, but not of EMCV, was impaired by interferons. The levels of 2'-5'-oligoadenylate synthetase mRNA and enzyme activity were similarly elevated upon interferon treatment in the two clones. However, the level of RNase L, as determined by binding and cross-linking of a radiolabeled 2'-5'-oligoadenylate derivative, was much lower in RK6 cells than in RK8 cells. In accord with this observation, the introduction of 2'-5'-oligoadenylates into cells inhibited protein synthesis much less strongly in RK6 cells than in RK8 cells. These results are consistent with the notion that the 2'-5'-oligoadenylate-dependent RNase L may be a mediator of the inhibition of EMCV replication by interferons.

This article has been cited by other articles:

• Ludwig, H., Suezer, Y., Waibler, Z., Kalinke, U., Schnierle, B. S., Sutter, G. (2006). Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara.. J. Gen. Virol. 87: 1145-1155 [Abstract] [Full Text]  
• Ludwig, H., Mages, J., Staib, C., Lehmann, M. H., Lang, R., Sutter, G. (2005). Role of Viral Factor E3L in Modified Vaccinia Virus Ankara Infection of Human HeLa Cells: Regulation of the Virus Life Cycle and Identification of Differentially Expressed Host Genes. J. Virol. 79: 2584-2596 [Abstract] [Full Text]  
• Kumar, S., Mitnik, C., Valente, G., Floyd-Smith, G. (2000). Expansion and Molecular Evolution of the Interferon-Induced 2'-5' Oligoadenylate Synthetase Gene Family. Mol Biol Evol 17: 738-750 [Abstract] [Full Text]  
• Kaufman, R. J. (1999). Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: A new role for an old actor. Proc. Natl. Acad. Sci. USA 96: 11693-11695 [Full Text]  
• Li, X.-L., Blackford, J. A., Hassel, B. A. (1998). RNase L Mediates the Antiviral Effect of Interferon through a Selective Reduction in Viral RNA during Encephalomyocarditis Virus Infection. J. Virol. 72: 2752-2759 [Abstract] [Full Text]  
• Tissot, C., Mechti, N. (1995). Molecular Cloning of a New Interferon-induced Factor That Represses Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression. J. Biol. Chem. 270: 14891-14898 [Abstract] [Full Text]